Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Ventavis® Registry Protocol (RESPIRE)

This study has been terminated.
(low enrollment rate and difficulty in recruiting eligible patients in adequate time)
Information provided by (Responsible Party):
Actelion Identifier:
First received: May 13, 2009
Last updated: July 16, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)